Phase IIa randomized, placebo-controlled study of antimicrobial photodynamic therapy in bacterially colonized, chronic leg ulcers and diabetic foot ulcers: a new approach to antimicrobial therapy

S. Morley, J. Griffiths, G. Philips, H. Moseley, C. O'Grady, K. Mellish, C. L. Lankester, B. Faris, R. J. Young, S. B. Brown, L. E. Rhodes (Lead / Corresponding author)

    Research output: Contribution to journalArticle

    69 Citations (Scopus)

    Abstract

    Background With increasing problems of antibiotic resistance, photodynamic therapy (PDT) is being developed as a novel antimicrobial treatment. Following light activation, cationic photosensitizer PPA904 [3,7-bis(N,N-dibutylamino) phenothiazin-5-ium bromide] kills a broad spectrum of bacteria in vitro and this has a variety of potential clinical applications. Objectives To determine if PDT in bacterially colonized chronic leg ulcers and chronic diabetic foot ulcers can reduce bacterial load, and potentially lead to accelerated wound healing. Methods Sixteen patients with chronic leg ulcers and 16 patients with diabetic foot ulcers (each eight active treatment/eight placebo) were recruited into a blinded, randomized, placebo-controlled, single-treatment, Phase IIa trial. All patients had ulcer duration > 3 months, bacterially colonized with > 10 colony-forming units cm . After quantitatively assessing pretreatment bacterial load via swabbing, PPA904 or placebo was applied topically to wounds for 15 min, followed immediately by 50 J cm of red light and the wound again sampled for quantitative microbiology. The wound area was measured for up to 3 months following treatment. Results Treatment was well tolerated with no reports of pain or other safety issues. In contrast to placebo, patients on active treatment showed a reduction in bacterial load immediately post-treatment (P
    Original languageEnglish
    Pages (from-to)617-624
    Number of pages8
    JournalBritish Journal of Dermatology
    Volume168
    Issue number3
    DOIs
    Publication statusPublished - 2013

    Fingerprint Dive into the research topics of 'Phase IIa randomized, placebo-controlled study of antimicrobial photodynamic therapy in bacterially colonized, chronic leg ulcers and diabetic foot ulcers: a new approach to antimicrobial therapy'. Together they form a unique fingerprint.

  • Cite this

    Morley, S., Griffiths, J., Philips, G., Moseley, H., O'Grady, C., Mellish, K., Lankester, C. L., Faris, B., Young, R. J., Brown, S. B., & Rhodes, L. E. (2013). Phase IIa randomized, placebo-controlled study of antimicrobial photodynamic therapy in bacterially colonized, chronic leg ulcers and diabetic foot ulcers: a new approach to antimicrobial therapy. British Journal of Dermatology, 168(3), 617-624. https://doi.org/10.1111/bjd.12098